HCA HEALTHCARE INC (HCA)
US40412C1018 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 58.752B 14.01% | 60.233B 2.52% | 64.968B 7.86% | 71.195B 9.58% | 75.499B 6.05% | 79.43B 5.21% | 85.153B 7.21% | 90.682B 6.49% | 95.055B 4.82% | 99.486B 4.66% | 104.109B 4.65% | |
| EBITDA YoY % growth | 12.531B 25.52% | 12.022B -4.06% | 12.704B 5.67% | 14.008B 10.26% | 14.873B 6.18% | 15.741B 5.84% | 16.705B 6.12% | 17.776B 6.41% | 18.739B 5.42% | 19.622B 4.71% | 20.543B 4.69% | |
| EBIT YoY % growth | 9.678B 33.27% | 9.053B -6.46% | 9.627B 6.34% | 10.689B 11.03% | 11.349B 6.17% | 11.922B 5.05% | 12.469B 4.59% | 13.333B 6.93% | 14.08B 5.60% | 14.747B 4.74% | 15.442B 4.71% | |
| Operating Margin | 16.47% | 15.03% | 14.82% | 15.01% | 15.03% | 15.01% | 14.64% | 14.70% | 14.81% | 14.82% | 14.83% | |
| EPS YoY % growth | 17.50 77.13% | 16.90 -3.43% | 18.66 10.41% | 22.07 18.29% | 24.76 12.19% | 27.56 11.31% | 31.32 13.62% | 35.72 14.07% | 39.66 11.03% | 43.45 9.55% | 47.47 9.25% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 6.14 3.53% | 5.85 -1.31% | 6.26 13.27% | 5.65 12.29% | 7.03 14.43% | 6.44 9.99% | 6.84 9.23% | 6.16 9.09% | 7.77 10.62% |
| Revenue Q2Q % growth | 18.43B 6.51% | 18.452B 6.42% | 18.68B 6.79% | 18.705B 6.97% | 19.497B 5.79% | 19.398B 5.13% | 19.644B 5.16% | 19.654B 5.07% | 20.576B 5.53% |
| EBITDA Q2Q % growth | 3.74B -36.37% | 3.574B 6.53% | 3.755B -13.58% | 3.518B -27.70% | 4.004B 7.06% | 3.758B 5.15% | 3.977B 5.91% | 3.724B 5.86% | 4.235B 5.77% |
| EBIT Q2Q % growth | 2.894B 3.32% | 2.711B 5.90% | 2.886B 5.68% | 2.635B 9.34% | 3.109B 7.43% | 2.867B 5.75% | 3.06B 6.03% | 2.787B 5.77% | 3.275B 5.34% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 5.03 28.64% | 5.04 | -0.01 | -0.18% |
| Q2 2024 Q2Q % growth | 5.53 28.90% | 4.90 | 0.63 | 12.83% |
| Q1 2024 Q2Q % growth | 5.93 30.91% | 5.04 | 0.89 | 17.74% |
| Q4 2023 Q2Q % growth | 5.93 27.80% | 5.11 | 0.82 | 15.99% |
| Q3 2023 Q2Q % growth | 3.91 -0.51% | 4.02 | -0.11 | -2.67% |
| Q2 2023 Q2Q % growth | 4.29 1.90% | 4.27 | 0.02 | 0.57% |
| Q1 2023 Q2Q % growth | 4.53 9.95% | 3.97 | 0.56 | 14.11% |
| Q4 2022 Q2Q % growth | 4.64 4.98% | 4.83 | -0.19 | -3.95% |
| Q3 2022 Q2Q % growth | 3.93 -14.00% | 3.92 | 0.01 | 0.26% |
| Q2 2022 Q2Q % growth | 4.21 -3.66% | 3.74 | 0.47 | 12.68% |
| Q1 2022 Q2Q % growth | 4.12 -0.48% | 4.29 | -0.17 | -3.99% |
| Q4 2021 Q2Q % growth | 4.42 7.02% | 4.58 | -0.16 | -3.45% |
| Q3 2021 Q2Q % growth | 4.57 138.02% | 4.13 | 0.44 | 10.66% |
| Q2 2021 Q2Q % growth | 4.37 191.33% | 3.19 | 1.18 | 36.81% |
| Q1 2021 Q2Q % growth | 4.14 77.68% | 3.36 | 0.78 | 23.30% |
| Q4 2020 Q2Q % growth | 4.13 33.66% | 3.64 | 0.49 | 13.43% |
| Q3 2020 Q2Q % growth | 1.92 -13.90% | 2.34 | -0.42 | -18.01% |
| Q2 2020 Q2Q % growth | 1.50 -32.13% | -0.39 | 1.89 | 479.94% |
| Q1 2020 Q2Q % growth | 2.33 -21.55% | 2.66 | -0.33 | -12.55% |
| Q4 2019 Q2Q % growth | 3.09 3.34% | 3.12 | -0.03 | -0.96% |
| Q3 2019 Q2Q % growth | 2.23 3.24% | 2.15 | 0.08 | 3.77% |
| Q2 2019 Q2Q % growth | 2.21 -3.49% | 2.49 | -0.28 | -11.18% |
| Q1 2019 Q2Q % growth | 2.97 27.47% | 2.35 | 0.62 | 26.48% |
| Q4 2018 Q2Q % growth | 2.99 | 2.61 | 0.38 | 14.60% |
| Q3 2018 Q2Q % growth | 2.16 | 1.92 | 0.24 | 12.33% |
| Q2 2018 Q2Q % growth | 2.29 | 2.18 | 0.11 | 5.02% |
| Q1 2018 Q2Q % growth | 2.33 | 2.10 | 0.23 | 11.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 17.487B 7.86% | 17.713B | -226M | -1.28% |
| Q2 2024 Q2Q % growth | 17.492B 10.28% | 17.217B | 275M | 1.60% |
| Q1 2024 Q2Q % growth | 17.339B 11.21% | 16.947B | 392M | 2.31% |
| Q4 2023 Q2Q % growth | 17.303B 11.65% | 16.682B | 621M | 3.72% |
| Q3 2023 Q2Q % growth | 16.213B 8.30% | 15.981B | 232M | 1.45% |
| Q2 2023 Q2Q % growth | 15.861B 7.02% | 15.772B | 89M | 0.56% |
| Q1 2023 Q2Q % growth | 15.591B 4.32% | 15.419B | 172M | 1.12% |
| Q4 2022 Q2Q % growth | 15.497B 2.87% | 15.767B | -270M | -1.71% |
| Q3 2022 Q2Q % growth | 14.971B -2.00% | 15.151B | -180M | -1.19% |
| Q2 2022 Q2Q % growth | 14.82B 2.67% | 14.872B | -52M | -0.35% |
| Q1 2022 Q2Q % growth | 14.945B 6.93% | 14.886B | 59M | 0.40% |
| Q4 2021 Q2Q % growth | 15.064B 5.39% | 15.526B | -462M | -2.98% |
| Q3 2021 Q2Q % growth | 15.276B 14.76% | 14.628B | 648M | 4.43% |
| Q2 2021 Q2Q % growth | 14.435B 30.42% | 13.756B | 679M | 4.94% |
| Q1 2021 Q2Q % growth | 13.977B 8.68% | 13.772B | 205M | 1.49% |
| Q4 2020 Q2Q % growth | 14.293B 5.69% | 14.131B | 162M | 1.15% |
| Q3 2020 Q2Q % growth | 13.311B 4.86% | 12.996B | 315M | 2.42% |
| Q2 2020 Q2Q % growth | 11.068B -12.17% | 10.192B | 876M | 8.59% |
| Q1 2020 Q2Q % growth | 12.861B 2.75% | 13.245B | -384M | -2.90% |
| Q4 2019 Q2Q % growth | 13.523B 10.18% | 13.502B | 21M | 0.16% |
| Q3 2019 Q2Q % growth | 12.694B 10.85% | 12.623B | 71M | 0.56% |
| Q2 2019 Q2Q % growth | 12.602B 9.31% | 12.739B | -137M | -1.08% |
| Q1 2019 Q2Q % growth | 12.517B 9.58% | 12.443B | 74M | 0.59% |
| Q4 2018 Q2Q % growth | 12.274B | 12.218B | 56M | 0.46% |
| Q3 2018 Q2Q % growth | 11.451B | 11.403B | 48M | 0.42% |
| Q2 2018 Q2Q % growth | 11.529B | 11.439B | 90M | 0.79% |
| Q1 2018 Q2Q % growth | 11.423B | 11.426B | -3M | -0.03% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.25% | -0.45% | -3.14% |
| Revenue | 0% | 0.53% | -0.16% | -0.59% |